Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cellsMarcos Quintela, Lewis W. Francis|Clinical Epigenetics|2023Cited by 7
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancerMarcos Quintela, Lewis W. Francis|British Journal of Cancer|2023Cited by 5
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasionLydia C. Powell, Lewis W. Francis|Frontiers in Cell and Developmental Biology|2025Cited by 2